Biography
Selected Publications
Contact Information

Biography

Sharon A. Riddler, M.D. is an Assistant Professor of Medicine in the Division of Infectious Diseases, a member of its HIV-AIDS Unit, and a Research Assistant Professor in the Department of Infectious Diseases and Microbiology in the Graduate School of Public Health. Dr. Riddler is the Medical Director of the Pitt Men's Study (Pittsburgh site of the Multicenter AIDS Cohort), and is responsible for the ongoing clinical evaluations and investigations at that unit. She is an investigator with the AIDS Clinical Research Unit and is currently involved in numerous clinical trials of antiretrovirals. She provides primary care to approximately 150 HIV-infected individuals and is a co-investigator on the HRSA-funded Pitt HIV Early Intervention Project.

Selected Publications

1. Harrold SM, Wang G, McMahon, DK, Riddler SA, Mellors JW, Becker JT, Caldararo R, Reinhart TA, Achim CL, and Wiley CA. Recovery of replication-competent HIV-1 infected circulating monocytes from individuals receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2002; 18:6:00-00.
   
   
2. Benson CA, Deeks SG, Brun SC, Gulick RM, Eron JJ, Kessler HA, Murphy RL, Hicks C, King M, Wheeler D, Feinberg J, Stryker R, Sax PE, Riddler, S, Thompson M, Real K, Hsu A, Kempf, Japour AJ, Sun E. Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1–infected protease inhibitor–experienced patients. JID 2002; 185;599-607.
   
   
3. Collier AC, Kalish LA, Busch MP, Gernsheimer T, Assmann SF, Lane TA, Asmuth DM, Lederman MM, Murphy EL, Kumar P, Kelley M, Flanigan TP, McMahon DK, Sacks HS, Kennedy MS, Holland PV, and the Viral Activation Transfusion Study Group (VATS). (Dr. Riddler is a member of the VATS). Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. The viral activation transfusion study: A randomized controlled trial. JAMA 2001; 285:1591-1601.
   
   
4. Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Munoz, A. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS. 2001; 15(3):347-55.
   
   
5. Skolasky RL, Phair J, Detels R, Riddler S, Margolick J, Jacobson LP. Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy. AIDS Research and Human Retroviruses 2001; 17(14):1311-1316.
   
   
6. Jacobson LP, Gore MF, Strathdee SA, Phair J, Riddler S, Detels R, for the MultiCenter AIDS Cohort Study. Therapy-naivete in the era of potent antiretroviral therapy. J Clinical Epidem 2001; 54:149-156.
   
   
7. Rinaldo CR, Huang X-L, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, McMahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW. Anti-human immunodeficiency virus type 1 (HIV-1) CD8+ T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1 infected patients with advanced immunodeficiency. J Virology 2000; 74:4127-4138.
   
   
8. Hennessey KA, Giorgi JV, Kaplan AH, Visscher BR, Gange S, Margolick JB, Riddler S, Phair J. Detels R. AIDS onset at high CD4 + cell levels is associated with high HIV load. AIDS Res Human Retro 2000; 16 (2):103-7.
   
   
9. Rinaldo, CR, Jr., Liebmann, J.M., Huang, X-L, Fan, Zheng, Al-Shboul, Q., McMahon, D.K., Day, Richard D., Riddler, S. and Mellors, J.W. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis 1999; 179:329-336.
   
   
10. Stein DS, Hoover DR, Graham NMH, Chu C, Detels R, Riddler, SA, Phair JP, Saah AJ. The effect of prophylaxis with dapsone on development of mycobacterium avium-intracellulare disease - an analysis of the Multicenter AIDS Cohort Study. Inf Dis Clin Prac 1998; 7:395-399.